Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $908M | $972M | $1.13B | $1.29B | $1.22B | $1.39B | $1.67B | $1.22B | $1.20B | $1.17B |
| Revenue growth | — | 7.1% | 16.6% | 14.1% | -5.9% | 14.4% | 19.9% | -27.1% | -1.3% | -2.7% |
| Gross profit | $274M | $329M | $417M | $482M | $466M | $513M | $570M | $445M | $465M | $462M |
| Gross margin | 30.2% | 33.8% | 36.8% | 37.3% | 38.3% | 36.9% | 34.2% | 36.6% | 38.7% | 39.5% |
| Operating income | $164M | $243M | $321M | $397M | $398M | $422M | $453M | $423M | $426M | $419M |
| Operating margin | 18.0% | 25.0% | 28.3% | 30.7% | 32.7% | 30.3% | 27.1% | 34.8% | 35.5% | 35.9% |
| Net income | $35.2M | $127M | $169M | $184M | $181M | $118M | $212M | -$5.40M | -$430M | -$167M |
| Net margin | 3.9% | 13.0% | 14.9% | 14.2% | 14.9% | 8.5% | 12.7% | -0.4% | -35.9% | -14.3% |
| EPS (diluted) | $0.83 | $2.97 | $3.97 | $4.35 | $4.37 | $2.95 | $5.50 | -$0.15 | -$11.85 | -$4.61 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $128M | $174M | $252M | $276M | $352M | $293M | $313M | $205M | $129M | $331M |
| Capital expenditures | $56.7M | $52.6M | $93.9M | $115M | $82.1M | $104M | $143M | $110M | $77.6M | $57.7M |
| Free cash flow | $71.2M | $122M | $158M | $161M | $270M | $190M | $171M | $95.3M | $51.0M | $274M |
| Share buybacks | $0.00 | $6.60M | $47.4M | $6.40M | $88.0M | $109M | $145M | $92.1M | $0.00 | $56.3M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $30.5M | $87.9M | $77.5M | $56.5M | $258M | $275M | $76.7M | $95.9M | $68.0M | $78.1M |
| Total assets | $833M | $930M | $1.32B | $2.14B | $2.33B | $2.47B | $2.74B | $2.62B | $2.02B | $1.65B |
| Total liabilities | $698M | $652M | $977M | $1.61B | $1.69B | $1.80B | $2.04B | $1.99B | $1.83B | $1.62B |
| Shareholders' equity | $127M | $264M | $339M | $531M | $642M | $674M | $698M | $631M | $195M | $29.7M |
| Retained earnings | $16.0M | $143M | $314M | $497M | $678M | $796M | $1.01B | $1.00B | $572M | $405M |
| Shares (wtd avg diluted) | 42.3M | 42.5M | 42.6M | 42.2M | 41.5M | 40.1M | 38.5M | 36.7M | 36.3M | 36.2M |
Every figure is extracted from Ingevity Corp’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.